Is Genflow Biosciences Plc (GENF.L) a Buy, Sell, or Hold?
LSE : GENF.L
Genflow Biosciences Plc — News
$1.9 GBp
-$0.09 (-4.52%)
- Volume
- 60K
- Average Volume
- 1.49M
- Market Capitalization
- $10.76M
- P/E Ratio
- -5.59
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $3.12
- Year Low
- $0.55
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.45
| Source | Headline |
|---|---|
|
Micron shares rise on Anthropic AI infrastructure partnership
Micron Technology Inc (NASDAQ:MU) shares rose more than 4% on Monday after the company announced a strategic agreement with Anthropic covering AI... proactiveinvestors.com - 2026-06-22 07:46:00 |
|
Genflow to present beagle gene therapy data at longevity summit
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5), the longevity research company, has been invited to present results from its SLAB clinical study... proactiveinvestors.com - 2026-06-17 03:13:00 |
|
Genflow surges 14% as animal health giants circle canine ageing gene therapy
The AIM-listed biotech's SIRT6 programme is attracting a widening group of Tier-1 industry evaluators, sending shares to 2.85p. Genflow Biosciences Ltd... proactiveinvestors.com - 2026-04-28 05:03:00 |
